Cardiovascular
2 drugs are in development for Pulmonary Hypertension.
- Companies
- 2
- Clinical trials
- 28
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Pulmonary Hypertension pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(2)
| Drug | Company |
|---|---|
| Ralinepag | UNITED THERAPEUTICS Corp (UTHR) |
| tnx-103 | TENAX THERAPEUTICS, INC. (TENX) |
About this indication
Pulmonary Hypertension context
Cardiovascular·MeSH: Hypertension, Pulmonary (D006976)
Prevalence
47000.0 / 100K
Incidence
3000.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Pulmonary Hypertension?
BioSniper tracks 2 drugs in development for Pulmonary Hypertension across 2 companies.
How many clinical trials target Pulmonary Hypertension?
There are 28 clinical trials targeting Pulmonary Hypertension tracked by BioSniper.
What is the prevalence of Pulmonary Hypertension?
The estimated prevalence of Pulmonary Hypertension is approximately 47000.0 per 100,000 population.